Clinical Scorecard: Advancements in Managing Postoperative Nausea and Vomiting Following Thyroid Surgery
At a Glance
Category
Detail
Condition
Postoperative Nausea and Vomiting (PONV)
Key Mechanisms
Multifactorial pathophysiology involving peripheral surgical stimulation, central emetic pathways, anesthetic-related mechanisms, and individual patient susceptibility.
Target Population
Patients undergoing thyroidectomy, particularly non-smoking females with a history of motion sickness or prior PONV.
Care Setting
Perioperative care for thyroid surgery.
Key Highlights
PONV occurs in approximately 60%-84% of thyroidectomy patients without effective prophylaxis.
Risk factors include female sex, non-smoking status, and history of motion sickness.
PONV can lead to serious complications such as aspiration pneumonia and airway compromise.
Evidence-based multimodal prophylactic strategies are recommended to reduce PONV.
Individualized antiemetic strategies are essential for improving postoperative outcomes.
Guideline-Based Recommendations
Diagnosis
Assess risk factors for PONV in patients undergoing thyroidectomy.
Management
Implement multimodal prophylactic strategies including TIVA, opioid-sparing techniques, and administration of 5-HT3 receptor antagonists and corticosteroids.
Monitoring & Follow-up
Monitor patients for signs of PONV within the first 24 hours post-surgery.
Risks
Consider the potential for complications such as cervical hematoma, wound dehiscence, and airway compromise due to PONV.
A large Epic Cosmos analysis linked vaginal estrogen prescribing with lower rates of sepsis, hospital admission, and death following recurrent urinary tract infection, but researchers cautioned that prescribing may also mark broader differences in care.
